secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quince Therapeutics, Inc. (QNCX)
CIK:        0001662774
Form:       8-K
Filed at:   2026-02-02T23:59:59+00:00
Accession:  0001193125-26-033758
Event type: leadership
Sentiment:  negative
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Five directors resign from Quince Therapeutics board effective immediately
--------------------------------------------------------------------------

- Directors Rajiv Patni, Luca Benatti, Margi McLoughlin, Una Ryan, and June Bray resigned on Jan 30, 2026.
- Resignations were not due to any disagreement with the company on operations, policies, or practices.
- CEO Dirk Thye remains as the sole executive officer; no replacements announced.
- Company continues under current management; board size reduced from six to one.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1662774/000119312526033758/0001193125-26-033758-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1662774/000119312526033758/d52597d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-033758

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer